ArticleJournal of Cancer2017

Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients.

Marjut Niinivirta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.